about
Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cellsLetrozole sensitizes breast cancer cells to ionizing radiationDirected evolution of single-chain Fv for cytoplasmic expression using the beta-galactosidase complementation assay results in proteins highly susceptible to protease degradation and aggregationSpecific in vivo labeling of tyrosinated α-tubulin and measurement of microtubule dynamics using a GFP tagged, cytoplasmically expressed recombinant antibodyRestricted diversity of antigen binding residues of antibodies revealed by computational alanine scanning of 227 antibody-antigen complexesTyrosine kinase syk non-enzymatic inhibitors and potential anti-allergic drug-like compounds discovered by virtual and in vitro screeningIn-cell intrabody selection from a diverse human library identifies C12orf4 protein as a new player in rodent mast cell degranulationSelection for intrabody solubility in mammalian cells using GFP fusionsA focused antibody library for selecting scFvs expressed at high levels in the cytoplasm.Selection and mass spectrometry characterization of peptides targeting semiconductor surfaces.Antibody targeting of claudin-1 as a potential colorectal cancer therapy.Synthetic customized scFv libraries.Specific extracellular matrix remodeling signature of colon hepatic metastases.Generation of an intrabody-based reagent suitable for imaging endogenous proliferating cell nuclear antigen in living cancer cells.Targeting the p38 MAPK pathway inhibits irinotecan resistance in colon adenocarcinoma.Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer.Enzyme immunoassays using bispecific diabodies.Crystallization of genetically engineered active maltose-binding proteins, including an immunogenic viral epitope insertion.Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein.Solubility Characterization and Imaging of Intrabodies Using GFP-Fusions.FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.New Topoisomerase I mutations are associated with resistance to camptothecinCyclophilin A as negative regulator of apoptosis by sequestering cytochrome c.Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins.ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.Enhancement of radiation therapy by tumor necrosis factor alpha in human colon cancer using a bispecific antibody.MAPK14/p38α confers irinotecan resistance to TP53-defective cells by inducing survival autophagy.Expression of single-chain Fv fragments in E. coli cytoplasm.Molecular and cellular targeting in the expression of foreign polypeptides in bacteria.Maltodextrin-binding protein hybrids carrying epitopes from the preS2 region of hepatitis B virus: expression, antibody-binding and preliminary crystallographic studies.NMR studies on the flexibility of the poliovirus C3 linear epitope inserted into different sites of the maltose-binding protein.Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump.Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins.Prognostic significance of TRAIL-R1 and TRAIL-R3 expression in metastatic colorectal carcinomas.A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally.Expression of an antibody fragment at high levels in the bacterial cytoplasm.Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.Construction of a Synthetic Antibody Gene Library for the Selection of Intrabodies and Antibodies.Immune responses to hybrid maltose-binding proteins.
P50
Q24646343-CEA1B38C-4E03-453D-B572-6FA7A2E7DCE7Q24797004-C6C6E286-BDA3-4C74-A2FF-0C0208CCAF20Q24803075-7D72E485-6FF7-4EDC-8E22-D10C34A36153Q27332419-5618C421-5BBD-4012-A6D5-041582BFB3C7Q27694831-ABCEA848-5458-46BF-AD2F-D26508D846CFQ28478649-2DC6222A-19D1-49A8-9901-4FC3378399DAQ28573830-8021E0A0-B697-4F44-80A2-B05770B16492Q31035688-5AD34E3A-02C0-46CB-AD7B-C1C0E231CAFBQ33307001-959CE537-65BF-40F5-966B-1197BBE325FBQ33487276-C8D844EE-6B91-490A-830B-055392652817Q33850900-528F9A8C-3CC2-474D-B505-300AE56DFF7FQ34386030-F9BCB508-F838-45A8-B8F9-E5F725F9B911Q34984735-2C1D7319-C067-477F-B608-9DEB41F92799Q35209715-1D3ADCAA-F89A-475E-93E0-CABE892E1BCCQ35832549-150C8996-A224-4170-B08D-BB813EB9BFC5Q36671593-2315249C-CBE8-4CB5-9CB2-BB1CD4E9BEF4Q36872928-94A98801-43A7-474A-8DD4-7C5E9D888E80Q38340392-679C834F-4894-4737-BE81-777BE070B998Q38350738-57B1B166-2540-4CD7-B940-535D8403F667Q38714053-E778B264-2977-422D-A425-11C20E7CC956Q38743209-DCFAE4CF-4967-4F29-B963-858D2BFE2166Q39534943-D15469B9-0D7A-405B-B979-126C8988C8A7Q39742626-951117AA-9C58-4F33-9288-8913078649F5Q40176311-BD5123BA-A56C-403E-ACCB-E9924976FCEFQ40391205-9090370B-F2F1-40FC-A5AA-786623B095FCQ40577436-05E9C483-14F8-4034-AA63-305BD71A5A96Q40661845-82942243-2C49-4EBB-AE0C-E865DBBBC8E0Q41900100-DB9109D4-DFB8-4DCF-9D2C-0B591FA1B6A8Q42738872-C8DE5D37-1138-45CC-B32B-4C302C58C13DQ44185673-A6833AFB-DEC4-4031-A4EE-1F85706CAC39Q44625714-213E9235-2998-46E3-93B9-D5D3A622F8FAQ45033317-B69ADA0D-2B50-420B-9C56-A02A4C76472FQ45736203-8CB7C284-A593-4C86-82EF-476F44324FECQ45777364-3688417C-2469-4CEC-B659-A3962E21EF43Q46405137-0618333F-4550-4746-AA15-2726A7A2A065Q46551677-64041EEB-E69E-479F-BADF-418AE70BA49BQ47885555-4E55499C-AFE9-4944-BAEB-B76D2D1DEAF7Q50036937-8517B1B0-CE87-4EA2-A1B5-421BAA9932C7Q50108511-ACE45E58-2566-4A80-9005-6B42E35E44BBQ50169635-E06A0242-C2E6-448F-AD85-A4883FD92B0D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pierre Martineau
@ast
Pierre Martineau
@en
Pierre Martineau
@es
Pierre Martineau
@nl
Pierre Martineau
@sl
type
label
Pierre Martineau
@ast
Pierre Martineau
@en
Pierre Martineau
@es
Pierre Martineau
@nl
Pierre Martineau
@sl
prefLabel
Pierre Martineau
@ast
Pierre Martineau
@en
Pierre Martineau
@es
Pierre Martineau
@nl
Pierre Martineau
@sl
P1053
N-4386-2017
P106
P1153
7007044886
P21
P31
P3829
P3835
pierre-martineau
P496
0000-0002-7993-7183